CHAPTERS
- 0:02 – 2:04
Berenson’s Twitter ban and the tweet that triggered it
Joe and Alex open with Berenson’s return to Twitter and why it’s unusual. Berenson recounts the August 2021 tweet about vaccines not stopping infection/transmission and how Twitter removed him permanently.
- •The specific tweet content and why Twitter called it a strike/ban
- •Rogan frames it as “vindication” as policies and narratives shift later
- •Loss of access: account wiped, followers cut off
- •Sets up the legal and political conflict that follows
- 2:04 – 6:57
Section 230 explained: immunity, moderation, and how platforms expanded power
Berenson lays out the legal backdrop: what Section 230 was meant to do versus how courts broadened it. He argues platforms gained both immunity from user content liability and near-total freedom to ban users.
- •Original intent: protect platforms from liability for user posts
- •Secondary intent: allow limited good-faith moderation (e.g., pornography)
- •Ninth Circuit decisions broadened protections dramatically
- •Why “repeal 230” may be the wrong fix; courts could reinterpret it
- 6:57 – 11:47
Berenson v. Twitter: the contract-based strategy and the judge’s ruling
Berenson explains how his case differed from most deplatforming lawsuits: he had internal Twitter emails suggesting he was within policy and Twitter encouraged debate. The judge allowed a breach-of-contract claim to proceed, opening the door to discovery.
- •Emails from Twitter exec Brandon Borman signaling Berenson was “fine”
- •Argument: platform policies modify the user contract and must be followed
- •Judge William Alsup allows key claims to proceed (April ruling)
- •Significance for internet law beyond Berenson’s individual case
- 11:47 – 14:48
Discovery leverage and settlement: reinstatement plus internal documents
The conversation turns to why Twitter settled: discovery and depositions can be a corporate nightmare. Berenson describes the July 6 reinstatement and the post-settlement release of internal documents suggesting government pressure.
- •Discovery and depositions as high-pressure litigation tools
- •Settlement outcome: reinstated; Twitter acknowledged the removal was wrong
- •Berenson begins publishing internal Twitter communications
- •Claim: federal government pressure contributed to the ban
- 14:48 – 21:17
White House pressure claims and the next lawsuit target
Berenson alleges internal Twitter discussions referenced White House displeasure with him months before the ban. He outlines plans to sue the Biden administration and specific officials, framing it as a First Amendment issue via state coercion of a private platform.
- •Internal notes: “Why is this guy still allowed to tweet?”
- •Timeline: public rhetoric (“killing people”) and subsequent strikes/ban
- •Planned suit against the White House and Andy Slavitt
- •Core allegation: government-induced censorship violates constitutional rights
- 21:17 – 23:50
Narrative shifts: masks, vaccines, boosters, and mandate-era politics
Rogan notes YouTube policy changes now allow statements once labeled misinformation. Berenson argues the real fight moved to mandates and boosters as vaccine effectiveness against transmission eroded, increasing political pressure to silence dissent.
- •Policy reversals: earlier claims later become permitted speech
- •Shift from persuasion (“lotteries”) to mandates tied to jobs and access
- •Berenson frames his reporting as data-driven journalism
- •Twitter “cracked” under political and institutional pressure
- 23:50 – 27:34
All-cause mortality and birth-rate concerns: the ‘hard questions’
Berenson pivots from transmission debates to population-level outcomes: all-cause deaths and potential fertility signals. He claims some countries show elevated mortality above baseline and discusses possible explanations beyond vaccines while insisting the topic must be investigated.
- •Claimed ~10% all-cause death elevation above baseline in some datasets
- •Possible fertility/birth-rate declines ~9 months after mass vaccination
- •Alternative explanations: deferred care, lifestyle changes, social disruption
- •Call for open inquiry rather than stigma-driven silence
- 27:34 – 39:24
Media incentives and coordinated narratives: from COVID to climate framing
They discuss sensational or implausible media explanations (e.g., heart attacks blamed on climate change). Berenson argues elite media became more coordinated post-2016, citing initiatives and a cultural monoculture that discourages dissenting coverage.
- •Critique of mainstream outlets publishing dubious causal claims
- •Post-2016 ‘coordination’ and distrust after Trump election
- •Trusted News Initiative as an example of agenda alignment
- •Parallel pattern emerging with climate coverage and other issues
- 39:24 – 1:02:16
Fauci clips, accountability, and why ‘rewriting history’ won’t work
Rogan and Berenson react to montage clips contradicting officials’ later claims. They speculate about Fauci’s departure and outline three exposure fronts: gain-of-function, lockdown advocacy, and vaccine partnerships/oversight.
- •Clips used to counter ‘I never said that’ narratives
- •Speculation: Fauci stepping down to avoid future subpoenas
- •Three issues: gain-of-function, lockdowns, vaccines/Moderna partnership
- •Liability shields and political protection reduce accountability pressure
- 1:02:16 – 1:25:07
Pharma influence, liability shields, and institutional reluctance to report injuries
Rogan emphasizes pharma advertising capture; Berenson stresses cultural and ideological drivers too. They discuss the lack of mainstream reporting on injuries and signals (e.g., adult-onset type 1 diabetes case reports) and why immunity from liability weakens scrutiny.
- •Pharma advertising dependence as a structural conflict of interest
- •Cultural justification: ‘greater good’ overrides messy truth
- •Signal events (autoimmune issues) versus large-scale incidence
- •Liability shields reduce discovery, trial-lawyer incentives, and investor pressure
- 1:25:07 – 1:34:47
VAERS, causality, and why signals are hard to prove case-by-case
They dig into what VAERS can and can’t prove and debate under- vs. ‘over-’reporting. Berenson argues VAERS is inherently noisy but becomes meaningful when patterns (like myocarditis) exceed expected baselines; common events (strokes) are harder to attribute.
- •VAERS captures reports, not confirmed causality
- •Argument: attention may reduce under-reporting but not create ‘over-reporting’
- •Case example: rare prion disease timing illustrates coincidence vs. signal
- •Myocarditis became undeniable due to scale and demographic skew
- 1:34:47 – 2:03:14
Omicron, immune imprinting, and disputes over what vaccines still do
Berenson claims vaccines became ineffective (or negative) against Omicron infection and possibly limited against severe disease. They discuss immune imprinting/original antigenic sin and skepticism about updated boosters built on earlier spike targets.
- •Omicron as an immune-escape variant shaped by uniform spike-focused immunity
- •Immune imprinting: updated boosters may still bias responses to original spike
- •Disagreement about remaining protection against severe outcomes
- •Broader concern: shifting goalposts and messaging integrity
- 2:03:14 – 2:27:59
Treatments debate: Paxlovid vs. ivermectin and standards of evidence
Berenson defends Paxlovid based on trial results while remaining unconvinced about ivermectin’s efficacy despite advocacy. Rogan presses on mechanisms and dosing disputes, and Berenson argues prospective trials should show clear benefit if a drug works broadly.
- •Paxlovid mechanism: protease inhibitor with strong trial outcomes cited
- •Ivermectin: mixed/negative prospective trial results per Berenson
- •Mechanism claims shift over time, fueling skepticism
- •Importance of trial design: prospective vs. retrospective comparisons
- 2:27:59
Vaccines portfolio: mRNA vs adenovirus vs protein/inactivated options—and why mRNA dominated
They compare vaccine platforms and question why alternatives (J&J/AZ, Novavax, inactivated vaccines) were sidelined in the U.S. Berenson suggests policy and institutional preference drove mRNA dominance, raising questions about decision-making and incentives.
- •Adenovirus vaccines: different durability profile; clot risks acknowledged
- •mRNA delivery via lipid nanoparticles and modified RNA; spike production shared goal
- •Novavax as direct spike-protein approach; low uptake
- •Why inactivated vaccines (China/India) weren’t pursued in the U.S.
Personal and professional fallout—and the rise of independent journalism
Berenson reflects on losing friends and relationship strain but says the story has been professionally ‘great’ because mainstream outlets won’t cover it. They discuss Substack, Spotify’s resistance to pressure, and the motivation that attacks create for independent reporters.
- •Personal costs: friendships and social consequences
- •Professional upside: exclusive access to whistleblowers and neglected leads
- •Independent platforms (Substack/Spotify) as new distribution infrastructure
- •Attacks and smears can intensify commitment to reporting
What Berenson says he got wrong, excess deaths theory, and why legacy media won’t engage
Berenson names specific errors (herd immunity optimism, early death projections) while returning to his central alarm: persistent excess mortality that doesn’t match ‘pull-forward’ expectations. He closes by pointing to his published documents and frustration that major outlets ignore them.
- •Admitted mistake: expected herd immunity/cross-immunity dynamics
- •Death-count nuance: ‘with’ vs ‘from’ and comorbidities complexity
- •Excess deaths vs ‘pull-forward’ prediction; Berenson suspects vaccine-related effects
- •Legacy media silence even on internal Twitter/White House pressure documents
